The third batch of national drug collection work started to strengthen supervision and prevent corruption.

In recent years, Quanzhou City, Fujian Province, reformed the traditional drug procurement model, the establishment of 268 medical insurance fixed-point medical institutions composed of Quanzhou City Sunshine Drug Mining Alliance.
map for Quanzhou City Sunshine Drug Harvesting Alliance called experts to select some drugs for consideration.
Xinhua News Agency reporter Wei Peiquan for the treatment of type 2 diabetes, the price of metformin hydrochloride tablets as low as 1.5 points per tablet, a drop of more than 90%; On August 20, the third batch of state-organized drugs with a procurement scale of tens of billions of yuan was opened in Shanghai, and the results of the proposed election were produced.
a total of 189 enterprises participated in this procurement, resulting in 125 enterprises to be selected, 191 to choose the drug product regulations, an average price reduction of 53%, the highest decline of 95%.
opening scene, a number of star drugs reported ultra-low prices.
an important project to promote people's livelihood and well-being, the implementation of the national centralized drug procurement system has not only accelerated the transformation of China's pharmaceutical industry, but also brought about real changes for the masses to see a doctor.
advantages of decentralized procurement over centralized procurement? How to squeeze out the drug price falsely high water? Can the selected drugs enter the medical institution smoothly? How will the positive trend of anti-corruption in the field of pharmaceutical purchase and sale deepen? Reinventing the drug price market discovery mechanism, with volume procurement crowding out virtually high moisture national organization drug centralized procurement and use pilot launched in early 2019 in 11 cities.
The centralized procurement and use of medicines by state organizations is an important measure to deepen the reform of the medical and health system, mainly in the form of "national organizations, alliance procurement, platform operation", aimed at promoting the linkage between medical, medical and pharmaceutical reform, breaking down and divideing medicine, and further reducing the burden of drug use by the masses.
October 2019, the State Health Security Administration and nine other departments issued a proposal on the implementation of the pilot expansion of the pilot of centralized procurement and use of drugs organized by the State, and expanded the scope of the pilot to the whole country.
, the pilot and enlargement are progressing smoothly, and the expansion areas began to implement the results of the expansion procurement at the end of last year, with the effect of the reform benefiting patients throughout the country.
the most immediate effect of the pilot and enlargement of the "Society" is to reduce the burden of patient costs.
of the drugs selected are high blood pressure, mental illness, viral hepatitis, malignant tumors and other chronic diseases and major diseases, long-term drug burden is very heavy.
through the volume of procurement significantly reduce the price of drugs, the original can not afford the medicine is now affordable, to solve the problem of access to treatment, which is the most direct benefit of the people.
the head of the Joint Procurement Office for the Central Procurement and Use of Medicines of the National Organization of The People's Republic of China.
can a large reduction in drug prices be made by purchasing with a band? Reporters learned that the traditional "recruitment separation" model there is only the problem of price without volume, quantity price decoupling, because there is no commitment to purchase volume, the lack of sales expectations, resulting in drug prices difficult to return to a reasonable level.
the national centralized organization with volume procurement model requires the use of end-of-use medical institutions must complete the promised amount of drug use, and truly realize the volume of procurement, recruitment and one.
under the design of such a system, drug procurement, use, medical insurance payment, payment settlement formed a closed loop, the middle unreasonable link was cancelled.
And in terms of absolute prices, a considerable part of the drug prices have long been false high moisture, some generic drug prices are more than 2 times higher than the international price, circulation costs accounted for the main part of the price, which is the main space for centralized volume procurement price reduction.
past, companies developed a new drug that could recruit two or three thousand marketing teams, with a high proportion of sales costs.
," said Fu Gang, vice president of the China Pharmaceutical Business Association and chairman of Baiyang Pharmaceutical Group. Zhai Bo, director of the pharmaceutical price and tender procurement department of the Shanghai Medical Security Bureau, said that the above-mentioned circulation links may be gray income, promotional behavior, and even illegal acts,
"with volume procurement can reshape the discovery mechanism of drug prices under the market mechanism, so that it can be changed in volume or price."
" In addition, from the historical procurement data, some of the production costs are not high, full competition of the original price level of drugs is very low, but because of the circulation model, low-cost drugs are difficult to open the market, high-priced drugs "reverse elimination."
to carry out centralized procurement of drugs organized by the state, enterprises no longer need to sell public relations, help to return the original low-cost drugs to patients.
" need to note that centralized procurement extrudes unreasonable water that has long existed in the field of circulation, rather than production costs, and does not affect the quality of medicines.
" joint procurement office, the person in charge of promoting the reform of centralized procurement of drugs, in order to avoid the phenomenon of "bad currency expulsion of good money" in the competition, the relevant departments in the original accessories of drugs, production technology, quality testing and efficacy and other aspects of the formulation of strict standards, and by contract to strengthen the selection of corporate responsibility, clear default punishment and disposal mechanism, while strengthening the selection of drugs supervision and inspection and product sampling, to ensure that price reduction does not reduce quality.
the situation in the pilot areas, the proportion of drugs used by the masses through consistent evaluation increased from about 50% to more than 90%, and the quality level of drug use improved significantly.
with the centralized procurement of drugs in various places have landed, many patients enjoy the benefits of visible touch.
Mr. Li, a resident of Jinan, Shandong Province, who has hepatitis B, found that the drug, which used to sell for 204.46 yuan, now costs only 27 yuan to buy a box.
Ms. Zhang, of Shenyang, Liaoning Province, also said that the price of her long-term anti-sugar drug Akapo tablets had dropped from 61.29 yuan to 5.42 yuan per box.
" to form a market brand effect, promote the transformation of national industry from generic drugs to innovative drugs Shanghai Sunshine Pharmaceutical Procurement Network published a list of procurement varieties shows that the third batch of centralized procurement work involving a total of 56 varieties, the number close to the first two batches of drugs, including diabetes, hypertension, cardiovascular and other diseases, anatrofen, ibuprofen, amoxilin, tetrachloretamine, oxycodone, metformin and other popular drugs are among them.
in order to ensure the stable supply of winning drugs, this collection in the second batch of mining on the basis of fine-tuning optimization, the maximum number of selected enterprises from the original 6 to 8.
on the opening day, 189 enterprises actively participate in a variety of drugs appear "floor price", of which, used to treat type 2 diabetes, metformin hydrochloride tablets are the most competitive, nearly 30 over-rated enterprises, the lowest price fell to 1.5 points per tablet, Qilu Pharmaceutical 25mg12 pieces of specifications of Xidana non also reported an average price of 2.08 yuan per tablet, a drop of 92%.
, 191 of the 55 drugs were included in the proposed selection.
" the third national collection once there are 55 kinds of drugs winning the bid, in the future to improve the concentration of pharmaceutical enterprises, regulate drug circulation links, improve the hospital drug catalog, improve the access of patients to drugs has played a great role.
," said Hu Shanlian, a professor at Fudan University's School of Public Health in Shanghai.
Chen Qiuxuan, deputy director of the Health Industry Development Research Center of the Chinese Academy of Social Sciences, said the collection also involved leukemia, anti-tumor, psychotic drugs, "these drugs are actually some of the drugs commonly used by patients, the people have a direct impact."
" it is worth noting that, compared with the second collection at the beginning of the year, most foreign pharmaceutical companies did not follow the price reduction, the winning enterprises are mostly local generic pharmaceutical enterprises, only a small number of original research varieties winning the bid.
, a professor at Peking University's School of Pharmacy, said that because of the decline in generic drug prices, quality assurance, patients after a period of time, more and more assured that the demand for generic drugs began to increase.
" With the continuous expansion of consistent evaluation, domestic enterprises gradually form a market brand effect, more energy to focus on research and development, in order to ensure the brand of generic drugs, to promote the transformation of national industry from generic drugs to innovative drugs.
" reporter noted that the Joint Procurement Office issued at the end of July the national drug centralized procurement document (GY-YD2020-1) on the declaration of enterprise qualifications have been strictly restricted, requiring the declaration of enterprises to participate in the drug centralized procurement activities in the first two years, in the pharmaceutical production activities must not have a serious illegal record, and the quality of drugs to be responsible.
, as the first responsible person for supply security, the production should be organized in a timely and sufficient manner according to the requirements, and the distribution enterprises should be sent drugs.
In addition, the reporting enterprise should fill in the national drug centralized procurement declaration commitment letter in advance, promise no interest relationship with the joint procurement office, will not make any improper contact with the purchaser to achieve the project, do not collude with other enterprises to declare, negotiate quotations, do not have a direct holding, management relationship with other enterprises of the same variety or the enterprise head of the same person, do not interfere with the centralized procurement-related work order, will not have any illegal violations in the reporting process to ensure fair and impartial collection work.
joint procurement office may also conduct an investigation into the pharmaceutical production and the quality of the drug to be selected by the proposed enterprise according to the needs of the work.
" compared with the first two batches, the third batch of procurement volume is greater, enterprises have adapted to the existing collection mechanism, proving that the first two batches to take good results.
" Chen Qiuxuan said, centralized procurement is not only in line with the laws of the industry, but also in line with the current reality, multi-benefit, should be constantly improved, and continue to promote.
has long been a high-risk area for drug procurement, as it continues to strengthen regulation and prevent corruption from being fostered in centralized procurement processes.
in the previous decentralized procurement model, some pharmaceutical companies do not pay attention to product innovation, quality and cost control, over-reliance on sales channels, so that drug sales staff and medical personnel face a greater risk of violations of the law.
by performance, high commission and other factors, the word pharmaceutical representative almost with the "high-priced medicine" painting, followed by drug rebates, over-medical problems have become difficult to eradicate dysentery.
According to industry sources, if there are multiple drugs in the hospital drug procurement catalog that can be used to treat the same disease, doctors often choose drugs with a high percentage of rebates, resulting in patients having to bear more treatment costs.
The former party committee member and vice president of Fuyang District Second People's Hospital in Hangzhou, Zhejiang Province, Sun Zhilong has 196 illegal drug rebates totalling more than 16 million yuan, of which, a company's pharmaceutical representative Lin promised to Sun Zhilong rebate costs as high as 45% of the drug price, the high price of the drug can be seen.
One of the advantages of centralized procurement and use of drugs by national organizations is that one of the advantages of the pilot and expansion of the procurement model is that under the premise of consistent quality and efficacy, different enterprises produce drugs of the same name compete with each other, so that the quality and efficacy of drugs from industry concerns to the attention of the whole society, operational space has been further compressed.
" centralized procurement model, enterprise public relations behavior will be greatly reduced, inter-enterprise competition into open and transparent product quality and cost competition, under the surface of the gray operation into the sun under the fair competition, fundamentally improve the ecological environment of the pharmaceutical industry, is conducive to the pharmaceutical industry from marketing-driven to innovation-driven transformation.
," said the head of the joint procurement office.
this, the drug collection model still faces many uncertainties in the process of implementation, such as enterprise default, hospital non-cooperation and abuse of power, and needs to further improve the mechanism and strengthen supervision.
reporter noted that the third batch of drug collection requirements to establish a declaration enterprise, selected enterprises, distribution enterprises violation list.
violations include providing prescription kickbacks or other commercial bribes, conducting illegal promotional activities, obtaining bribes from buyers, joint procurement offices, etc., and providing false supporting documents and documentation to cheat the election.
listed in violation of the list will be disqualified from the selection, and depending on the serious circumstances of the enterprise or variety in the list of violations within 2 years from the date of participation in the centralized procurement activities of drugs in various places.
can we ensure the smooth access of the selected drugs to medical institutions? The relevant person in charge of the Medical Administration of the National Health and Health Commission said that the requirements of medical institutions have been made and that the reasonable use and guarantee of supply of selected drugs should not be affected by requirements such as cost control, the proportion of drugs and the quantity of medical institutions' product regulations.
, the health department should strengthen the guidance and supervision of public medical institutions, and urge public medical institutions to give priority to the procurement and use of selected medicines in accordance with the agreed procurement volume.
the promotion of centralized procurement and use of drugs and expansion of drug organizations, the same can not be separated from the protection of supervisory power.
The discipline inspection and supervision team of the Dongguan Municipal Commission for Discipline Inspection and Supervision of the Municipal Health Insurance Bureau of Guangdong Province will target the daily supervision probe in the field of centralized procurement management of drugs, urge the responsible subjects of the relevant business departments to investigate risks from four aspects, such as "job responsibilities", "business process" "system mechanism" and "external environment", establish and improve the risk prevention and control system of integrity in key key links of key posts, and conduct integrity assessment of centralized procurement organizations, product selection, work processes, etc., to ensure the legal compliance of the centralized procurement process.
" on the centralized procurement management of violations of discipline, we firmly and strictly deal with, strengthen the responsibility must be asked, accountability must be strict clear guidance.
the relevant person in charge of the discipline inspection and supervision group said.
, the State Health and Health Commission issued the "2020 Special Action Plan for the Construction of The Style of The Medical Industry", which calls for strengthening the comprehensive management of drug circulation, bidding, procurement, clinical use and other links, establishing a bad record of commercial bribery in the field of pharmaceutical purchase and sale, and handling the production and operation of pharmaceuticals, medical equipment and medical supplies included in the bad records in accordance with the regulations.
With the deepening of medical reform, the field of pharmaceutical purchase and sale of positive wind anti-corruption is also steadily advancing, tightening the red line of the system, and continuously strengthen supervision, in order to prevent the "central procurement" process of breeding corruption, to ensure that the state organization of centralized procurement and use of drugs pilot and expansion in the sun, and constantly consolidate the positive atmosphere of the industry.
.